Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028

AI in Healthcare Market Growth - The Generative AI in Healthcare Market is projected to reach US$17.2 billion by 2032, growing at a CAGR of 37% [2] - The Smart Healthcare Market, including telemedicine, mHealth, smart pills, and AI, is expected to grow by US$125.7 billion through 2028 [2] Avant Technologies and Ainnova Partnership - Avant Technologies and Ainnova have secured an exclusive license for 4 advanced AI algorithms for early detection of cardiovascular risk, prediabetes and type 2 diabetes, fatty liver disease, and chronic kidney disease [3][4] - These algorithms, validated with data from over 2 million patients, will be integrated into Ainnova's VisionAI platform [3][4] - The partnership aims to introduce these solutions in Latin America and secure FDA clearance for the U.S. market by 2025 [5][6] Industry Developments - Recursion Pharmaceuticals reported positive initial data from a Phase 1/2 study of REC-617, a CDK7 inhibitor, showing durable partial responses in advanced solid tumors [9][10] - Teladoc Health launched AI-enabled Virtual Sitter capabilities, increasing inpatient team capacity by 25% [10][11] - Butterfly Network partnered with HeartFocus to launch an AI-powered education app for cardiac care training [11][12] - Absci Corporation announced progress in its AI-driven drug creation pipeline, including potential treatments for hair loss and other conditions [12][13] Healthcare Professionals' Perspective - 90% of healthcare professionals report a favorable view of AI, highlighting its potential to transform clinical trials and healthcare delivery [1]